Home » Topics » Disease categories and therapies » Hematologic

Hematologic
RSS

Phase IIIa study of Neutralase halted

Sep. 25, 2003

Dual thrombin/factor Xa inhibitors evaluated as anticoagulants

Sep. 23, 2003

Novel benzamidine-based factor Xa inhibitors in Morphochem pipeline

Sep. 22, 2003

BMS-561389/DPC-906 as a phase II candidate for oral anticoagulant therapy

Sep. 18, 2003

Ximelagatran prevents recurrence of cardiovascular events after myocardial infarction

Sep. 18, 2003

New antithrombotic serine protease inhibitor patented by former Pharmacia

Sep. 17, 2003

First antithrombotic agent that acts by inhibiting Bruton's tyrosine kinase (BTK)

Sep. 16, 2003

Merck presents synthesis, SAR for a series of imidazole acetic acid TAFI inhibitors

Sep. 15, 2003

AxyS presents novel factor VIIa/factor Xa inhibitors

Sep. 12, 2003

New TAFI inhibitors for thrombotic disorders under evaluation at Pfizer

Sep. 3, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 9, 2026.
New York University identifies new analogues of mannose-6-phosphate
BioWorld Science
New York University has discovered new analogues of mannose-6-phosphate reported to be potentially useful for the treatment of memory impairment,...
ASCO 2026: Chinese biopharma arrives at ASCO with pivotal wins
BioWorld
If the 2026 American Society of Clinical Oncology (ASCO) annual meeting in Chicago from May 30 to June 3 demonstrated anything about the evolution of China’s...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Skape Bio unlocks GPCR targets with de novo-designed miniproteins
BioWorld
Modulating G protein-coupled receptors (GPCRs) is one of the major challenges in biomedicine. These are flexible proteins with small, deep binding pockets. The...